Interdependence of neural network dysfunction and microglial alterations in Alzheimer’s disease-related models

[1]  E. Aronica,et al.  Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury , 2021, Science.

[2]  L. Mucke,et al.  Phenotypic Differences between the Alzheimer’s Disease-Related hAPP-J20 Model and Heterozygous Zbtb20 Knock-Out Mice , 2021, eNeuro.

[3]  L. Mucke,et al.  Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies , 2021, Science.

[4]  J. Brouillette,et al.  Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease , 2021, Frontiers in Molecular Neuroscience.

[5]  Long-Jun Wu,et al.  How microglia sense and regulate neuronal activity , 2020, Glia.

[6]  P. Edison,et al.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? , 2020, Nature Reviews Neurology.

[7]  Mark Ellisman,et al.  Microglial Gi-dependent dynamics regulate brain network hyperexcitability , 2020, Nature neuroscience.

[8]  A. Tenner,et al.  The good, the bad, and the opportunities of the complement system in neurodegenerative disease , 2020, Journal of neuroinflammation.

[9]  Alice D. Lam,et al.  Night Watch on the Titanic: Detecting Early Signs of Epileptogenesis in Alzheimer Disease , 2020, Epilepsy currents.

[10]  L. Mucke,et al.  Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1 , 2020, Molecular Neurodegeneration.

[11]  Ukpong B. Eyo,et al.  Negative feedback control of neuronal activity by microglia , 2020, Nature.

[12]  Alice D. Lam,et al.  Association of epileptiform abnormalities and seizures in Alzheimer disease , 2020, Neurology.

[13]  A. Singer,et al.  Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute Neuroinflammation , 2019, The Journal of Neuroscience.

[14]  Y. Ikegaya,et al.  Synaptic Pruning by Microglia in Epilepsy , 2019, Journal of clinical medicine.

[15]  B. Han,et al.  A novel mutation of SATB2 inhibits odontogenesis of human dental pulp stem cells through Wnt/β-catenin signaling pathway , 2021, Stem Cell Research & Therapy.

[16]  Y. Ishihara,et al.  Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine , 2019, Neuroscience Letters.

[17]  José Luis Molinuevo,et al.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders , 2019, Journal of Alzheimer's disease : JAD.

[18]  I. Petrof,et al.  Early Seizure Activity Accelerates Depletion of Hippocampal Neural Stem Cells and Impairs Spatial Discrimination in an Alzheimer's Disease Model. , 2019, Cell reports.

[19]  Abigail L. Paulson,et al.  Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition , 2019, Cell.

[20]  Beth Stevens,et al.  Immune Signaling in Neurodegeneration. , 2019, Immunity.

[21]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[22]  Julie A. Harris,et al.  Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer’s disease , 2018, bioRxiv.

[23]  D. Holtzman,et al.  New insights into the role of TREM2 in Alzheimer’s disease , 2018, Molecular Neurodegeneration.

[24]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[25]  M. Colonna,et al.  TREM2 — a key player in microglial biology and Alzheimer disease , 2018, Nature Reviews Neurology.

[26]  F. Azuaje,et al.  Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures , 2018, EMBO reports.

[27]  Evan Z. Macosko,et al.  Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain , 2018, Cell.

[28]  T. Woodruff,et al.  New tricks for an ancient system: Physiological and pathological roles of complement in the CNS. , 2018, Molecular immunology.

[29]  R. Ransohoff,et al.  The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease , 2018, Molecular Neurodegeneration.

[30]  A. Lim,et al.  Molecular basis for the loss-of-function effects of the Alzheimer's disease–associated R47H variant of the immune receptor TREM2 , 2018, The Journal of Biological Chemistry.

[31]  L. Mucke,et al.  Istradefylline reduces memory deficits in aging mice with amyloid pathology , 2018, Neurobiology of Disease.

[32]  A. Brewster,et al.  Status epilepticus triggers long-lasting activation of complement C1q-C3 signaling in the hippocampus that correlates with seizure frequency in experimental epilepsy , 2018, Neurobiology of Disease.

[33]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[34]  Anastasia G. Efthymiou,et al.  Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk , 2017, Molecular Neurodegeneration.

[35]  E. Dardiotis,et al.  A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature , 2017, Neurobiology of Aging.

[36]  Alice D. Lam,et al.  Silent Hippocampal Seizures and Spikes Identified by Foramen Ovale Electrodes in Alzheimer’s Disease , 2017, Nature Medicine.

[37]  Ukpong B. Eyo,et al.  Microglia–Neuron Communication in Epilepsy , 2017, Glia.

[38]  Heidi E Kirsch,et al.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.

[39]  E. Boyden,et al.  Gamma frequency entrainment attenuates amyloid load and modifies microglia , 2016, Nature.

[40]  Ronald C. Petersen,et al.  TYROBP genetic variants in early-onset Alzheimer's disease , 2016, Neurobiology of Aging.

[41]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[42]  W. Löscher,et al.  Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond , 2016, CNS Drugs.

[43]  C. Kawas,et al.  Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study , 2016, Alzheimer's & Dementia.

[44]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[45]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[46]  Jaime Grutzendler,et al.  Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity , 2016, The Journal of Neuroscience.

[47]  M. Meyer-Luehmann,et al.  Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders? , 2015, Trends in Neurosciences.

[48]  S. Strittmatter,et al.  Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model , 2015, Alzheimer's Research & Therapy.

[49]  F. Giostra,et al.  Methods and Results , 2014 .

[50]  Caroline L. Speck,et al.  Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance , 2015, NeuroImage: Clinical.

[51]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[52]  Weikun Guo,et al.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory , 2014, Nature Neuroscience.

[53]  C. Combs,et al.  Iba1 immunoreactivity is enhanced following an antigen retrieval treatment with EDTA, pH 6.0 , 2014, MethodsX.

[54]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[55]  Teng Jiang,et al.  Microglia in Alzheimer's Disease , 2014, BioMed research international.

[56]  Ukpong B. Eyo,et al.  Neuronal Hyperactivity Recruits Microglial Processes via Neuronal NMDA Receptors and Microglial P2Y12 Receptors after Status Epilepticus , 2014, The Journal of Neuroscience.

[57]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[58]  Hong-Guang Xie,et al.  Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice , 2013, CNS neuroscience & therapeutics.

[59]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[60]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[61]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[62]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[63]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[64]  Keith A. Vossel,et al.  Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model , 2012, Proceedings of the National Academy of Sciences.

[65]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[66]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[67]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[68]  Jee Hoon Roh,et al.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.

[69]  L. Mucke,et al.  Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.

[70]  L. Mucke,et al.  Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[71]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[72]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[73]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[74]  Jacob Raber,et al.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Tony Wyss-Coray,et al.  Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.

[76]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[77]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[78]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[79]  J. Aten,et al.  Measurement of co‐localization of objects in dual‐colour confocal images , 1993, Journal of microscopy.

[80]  W. Hickey,et al.  Characterization of microglia and macrophages in the central nervous system of rats: Definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction , 1993, Glia.

[81]  A. Okumura,et al.  Effects of antiepileptic drugs on microglial properties , 2018 .

[82]  A. Szűcs,et al.  Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity. , 2017, Journal of Alzheimer's disease : JAD.

[83]  Wei Dai,et al.  Summary and discussion of : “ Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis ” , 2014 .

[84]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[85]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.